Using CD22/CD19 CAR T-cell therapy followed by autologous stem cell transplant (ASCT) showed promising results in patients with Philadelphia chromosome (Ph)–negative B-cell acute lymphoblastic ...
Please provide your email address to receive an email when new articles are posted on . A sequential CAR-T and HSCT regimen did not need preconditioning or GVHD prophylaxis to confer remission for CD7 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback